» Articles » PMID: 11097601

Risk Factors Associated with Age-related Macular Degeneration. A Case-control Study in the Age-related Eye Disease Study: Age-Related Eye Disease Study Report Number 3

Overview
Journal Ophthalmology
Publisher Elsevier
Specialty Ophthalmology
Date 2000 Nov 30
PMID 11097601
Citations 326
Affiliations
Soon will be listed here.
Abstract

Objective: To investigate possible risk factors for age-related macular degeneration (AMD) in participants in the Age-Related Eye Disease Study (AREDS).

Design: Case-control study.

Participants: Of the 4757 persons enrolled in AREDS, 4519 persons aged 60 to 80 years were included in this study. The lesions associated with AMD ranged from absent in both eyes to advanced in one eye.

Main Outcome Measures: Stereoscopic color fundus photographs of the macula were used to place participants into one of five groups, based on the frequency and severity of lesions associated with AMD. Participants with fewer than 15 small drusen served as the control group.

Results: Staged model building techniques were used to compare each of the four case groups with the control group. Increased age was a consistent finding of all four of the case groups compared with the control group, and all the following associations were age adjusted. Persons with either intermediate drusen, extensive small drusen, or the pigment abnormalities associated with AMD (group 2) were more likely to be female, more likely to have a history of arthritis, and less likely to have a history of angina. Persons with one or more large drusen or extensive intermediate drusen (group 3) were more likely to use hydrochlorothiazide diuretics and more likely to have arthritis. Hypertension, hyperopia, presence of lens opacities, and white race were also found more frequently in this group as well as in persons with neovascular AMD (group 5). Only persons in group 5 were more likely to have an increased body mass index, whereas persons with geographic atrophy (group 4) as well as those in groups 3 and 5 were more likely to have completed fewer years in school or to be smokers. Those with geographic atrophy were also more likely to use thyroid hormones and antacids.

Conclusions: Our findings for smoking and hypertension, which have been noted in previous studies, suggest that two important public health recommendations, the avoidance of smoking and the prevention of hypertension, may reduce the risk of developing AMD. Other associations, such as those for hyperopia, lens opacities, less education, female gender, increased body mass index, and white race, which have been noted in other studies, are also seen in the AREDS population. The increased use of thyroid hormones and antacids in persons with geographic atrophy and the increased likelihood of arthritis or hydrochlorothiazide use in persons with one or more large drusen or extensive intermediate drusen have not been previously reported and need additional investigation.

Citing Articles

Association between the dietary omega-6 to omega-3 fatty acid ratio and age-related macular degeneration in Korean adults.

Jang W, Kim Y, Kim H Nutr J. 2025; 24(1):29.

PMID: 40059179 PMC: 11892259. DOI: 10.1186/s12937-025-01090-z.


Resveratrol Protects Photoreceptors in Mouse Models of Retinal Degeneration.

Li S, Ma H, Ding X Antioxidants (Basel). 2025; 14(2).

PMID: 40002341 PMC: 11851417. DOI: 10.3390/antiox14020154.


A Comprehensive Health Screening Program Reveals the Prevalence of and Risk Factors for Age-Related Macular Degeneration: A Cross-Sectional Analysis.

Ma D, Oh B, Bak E, Kim J, Lee J, Choi H Biomedicines. 2025; 12(12.

PMID: 39767587 PMC: 11727633. DOI: 10.3390/biomedicines12122681.


Machine learning derived retinal pigment score from ophthalmic imaging shows ethnicity is not biology.

Rajesh A, Olvera-Barrios A, Warwick A, Wu Y, Stuart K, Biradar M Nat Commun. 2025; 16(1):60.

PMID: 39746957 PMC: 11696055. DOI: 10.1038/s41467-024-55198-7.


Global burden of low vision and blindness due to age-related macular degeneration from 1990 to 2021 and projections for 2050.

Zhang S, Ren J, Chai R, Yuan S, Hao Y BMC Public Health. 2024; 24(1):3510.

PMID: 39695517 PMC: 11657136. DOI: 10.1186/s12889-024-21047-x.


References
1.
Hyman L, LILIENFELD A, Ferris 3rd F, Fine S . Senile macular degeneration: a case-control study. Am J Epidemiol. 1983; 118(2):213-27. DOI: 10.1093/oxfordjournals.aje.a113629. View

2.
Sperduto R, Hiller R . Systemic hypertension and age-related maculopathy in the Framingham Study. Arch Ophthalmol. 1986; 104(2):216-9. DOI: 10.1001/archopht.1986.01050140070022. View

3.
Blumenkranz M, Russell S, Robey M, Penneys N . Risk factors in age-related maculopathy complicated by choroidal neovascularization. Ophthalmology. 1986; 93(5):552-8. DOI: 10.1016/s0161-6420(86)33702-3. View

4.
Gibson J, Shaw D, Rosenthal A . Senile cataract and senile macular degeneration: an investigation into possible risk factors. Trans Ophthalmol Soc U K (1962). 1986; 105 ( Pt 4):463-8. View

5.
Wang J, Mitchell P, Smith W . Refractive error and age-related maculopathy: the Blue Mountains Eye Study. Invest Ophthalmol Vis Sci. 1998; 39(11):2167-71. View